Lithuania vs United States of America: Share of one-year-olds vaccinated against rotavirus
Lithuania
77.0%
in 2024
United States of America
77.0%
in 2024
Lithuania rank
67th
United States of America rank
67th
Share of one-year-olds vaccinated against rotavirus over time
- Lithuania
- United States of America
How they compare
Lithuania currently reports 77.0% against 77.0% in United States of America, a difference of 0.0%.
Across all 7 years both countries report, United States of America has been ahead every year.
Lithuania ranks 67th and United States of America ranks 67th of 108 countries.
United States of America has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lithuania | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 23.0% | 73.5% | 50.5% | United States of America |
| 2020s | 59.2% | 76.4% | 17.2% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against rotavirus, Lithuania or United States of America?
- Lithuania, at 77.0% against 77.0% in United States of America as of 2024.
- What is the difference in share of one-year-olds vaccinated against rotavirus between Lithuania and United States of America?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and United States of America?
- 7 years are reported by both, from 2018 to 2024.
- How do Lithuania and United States of America rank globally for share of one-year-olds vaccinated against rotavirus?
- Lithuania ranks 67th and United States of America ranks 67th of 108 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against rotavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the final recommended dose (2nd or 3rd) of the rotavirus vaccine in a given year.